Quick Answer
ANI PHARMACEUTICALS INC reported Long-Term Debt of $291.84 million for fiscal year 2025.
ANI PHARMACEUTICALS INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $291.84M | -5.6% |
| 2024 | $309.11M | +8.5% |
| 2023 | $284.82M | -0.3% |
| 2022 | $285.67M | -0.3% |
| 2021 | $286.52M | +66.2% |
| 2020 | $172.44M | -1.9% |
| 2019 | $175.81M | +161.2% |
| 2018 | $67.30M | -3.8% |
| 2017 | $69.95M | — |
| 2016 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $297.68M | -4.9% | -1.3% |
| June 30, 2025 | $301.48M | +6.0% | -1.2% |
| March 31, 2025 | $305.29M | +7.3% | -1.2% |
| December 31, 2024 | $309.11M | +8.5% | -1.2% |
| September 30, 2024 | $312.92M | +9.8% | +10.0% |
| June 30, 2024 | $284.39M | -0.3% | -0.1% |
| March 31, 2024 | $284.61M | -0.3% | -0.1% |
| December 31, 2023 | $284.82M | -0.3% | -0.1% |
- ANI PHARMACEUTICALS INC showed a decrease of -5.6% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: